Compare · AAPL vs OMCL
AAPL vs OMCL
Side-by-side comparison of Apple Inc. (AAPL) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AAPL and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- AAPL is the larger of the two at $4.52T, about 2984.7x OMCL ($1.52B).
- AAPL has been more active in the news (10 items in the past 4 weeks vs 5 for OMCL).
- AAPL has more recent analyst coverage (25 ratings vs 24 for OMCL).
- Company
- Apple Inc.
- Omnicell Inc.
- Price
- -
- -
- Market cap
- $4.52T
- $1.52B
- 1M return
- -
- -19.95%
- 1Y return
- -
- +1.42%
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1980
- 2001
- News (4w)
- 10
- 5
- Recent ratings
- 25
- 24
Apple Inc.
Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. It also sells various related services. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, HomePod, iPod touch, and other Apple-branded and third-party accessories. It also provides AppleCare support services; cloud services store services; and operates various platforms, including the App Store, that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts. In addition, the company offers various services, such as Apple Arcade, a game subscription service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It sells and delivers third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was founded in 1977 and is headquartered in Cupertino, California.
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest AAPL
- Apple introduces new Mac Studio with M5 Max and M5 Ultra — the ultimate desktop for on-device AI and the most extreme pro workflows
- Apple’s new Mac mini, featuring M6 and M5 Pro, delivers a massive leap in AI performance, supercharging the leading desktop for always-on agentic computing
- Apple introduces M6 and M5 Ultra for a big leap in performance and AI compute
- SVP, GC and Secretary Newstead Jennifer sold $442,478 worth of shares (1,439 units at $307.49) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 38,668 units (SEC Form 4)
- Apple upgraded by Rothschild & Co Redburn with a new price target
- SVP, GC and Secretary Newstead Jennifer sold $442,852 worth of shares (1,439 units at $307.75) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 40,107 units (SEC Form 4)
- Apple opens Advanced Manufacturing Center in Houston
- Apple downgraded by Jefferies with a new price target
- Apple downgraded by China Renaissance with a new price target
- Apple downgraded by DZ Bank with a new price target
Latest OMCL
- EVP&CHIEF LEGAL/ADMIN OFFICER Manley Corey J covered exercise/tax liability with 4,025 shares, decreasing direct ownership by 4% to 108,985 units (SEC Form 4)
- VP, Chief Accounting Officer Nutt Brian H. covered exercise/tax liability with 937 shares, decreasing direct ownership by 4% to 22,266 units (SEC Form 4)
- President & COO Njoku Nnamdi covered exercise/tax liability with 3,670 shares and sold $113,609 worth of shares (3,083 units at $36.85) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 161,224 units (SEC Form 4)
- CHAIRMAN, CEO Lipps Randall A covered exercise/tax liability with 12,350 shares, decreasing direct ownership by 2% to 511,096 units (SEC Form 4)
- SEC Form 10-Q filed by Omnicell Inc.
- EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
- Omnicell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Omnicell Announces Second Quarter 2026 Financial Results
- CHAIRMAN, CEO Lipps Randall A sold $470,000 worth of shares (10,000 units at $47.00) as part of a pre-agreed trading plan (SEC Form 4)
- Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026